These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7511245)

  • 21. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus.
    Graham S; Wang EC; Jenkins O; Borysiewicz LK
    J Virol; 1993 Mar; 67(3):1627-37. PubMed ID: 7679749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of a predicted N-terminal amphipathic α-helix using atomistic molecular dynamics simulation of a complete prototype poliovirus virion.
    Roberts JA; Kuiper MJ; Thorley BR; Smooker PM; Hung A
    J Mol Graph Model; 2012 Sep; 38():165-73. PubMed ID: 23085162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A homology modeling method of an icosahedral viral capsid: inclusion of surrounding protein structures.
    Yoneda T; Yoneda S; Takayama N; Kitazawa M; Umeyama H
    J Mol Graph Model; 1999 Apr; 17(2):114-9, 137-42. PubMed ID: 10680117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
    Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
    J Virol; 2018 May; 92(9):. PubMed ID: 29444940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
    Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
    Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
    Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural, biochemical and electrostatic basis of serotype specificity in bovine enteroviruses.
    Smyth MS; Martin JH
    Arch Virol; 2001; 146(2):347-55. PubMed ID: 11315642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of the antigen and the antibody of the JC virus major capsid protein VP1.
    Chang D; Liou ZM; Ou WC; Wang KZ; Wang M; Fung CY; Tsai RT
    J Virol Methods; 1996 May; 59(1-2):177-87. PubMed ID: 8793846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity of the polioviral proteinase 3C towards genetically engineered cleavage sites in the viral capsid.
    Mirzayan C; Ingraham R; Wimmer E
    J Gen Virol; 1991 May; 72 ( Pt 5)():1159-63. PubMed ID: 1851816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon.
    Rux JJ; Burnett RM
    Mol Ther; 2000 Jan; 1(1):18-30. PubMed ID: 10933908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A model of the secondary structure and distribution of antigenic determinants in the VP1 protein of hepatitis A virus].
    Mesianzhinov VV
    Biofizika; 1986; 31(6):961-3. PubMed ID: 2432945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.
    Sedlik C; Sarraseca J; Rueda P; Leclerc C; Casal I
    J Gen Virol; 1995 Sep; 76 ( Pt 9)():2361-8. PubMed ID: 7561778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of fusions to viral coat proteins as antigenic carriers for vaccine development.
    Stockley PG; Mastico RA
    Methods Enzymol; 2000; 326():551-69. PubMed ID: 11036664
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
    Reynolds C; Page G; Zhou H; Chow M
    Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3.
    Evans DM; Minor PD; Schild GS; Almond JW
    Nature; 1983 Aug 4-10; 304(5925):459-62. PubMed ID: 6192344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
    Halim S; Ramsingh AI
    Virology; 2000 Mar; 269(1):86-94. PubMed ID: 10725201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
    Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
    J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational study of a nine residue fragment of the antigenic loop of foot-and-mouth disease virus.
    Vega MC; Aleman C; Giralt E; Perez JJ
    J Biomol Struct Dyn; 1992 Aug; 10(1):1-13. PubMed ID: 1329841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.